Detail

Study ID: COG ACNS1422

Title:

A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-RiskWNT-Driven Medulloblastoma Patients

Location:
Fargo Region, Sioux Falls Region
Principal Investigator:
Kayelyn Wagner, MD,Samuel Anim, MD
Disease:
CNS (Brain Tumors)
Stage:
Phase II
Status:
Active - Open to Accrual